law

ZITA , ZITAMET OR JANUVIA , JANUMET ?

Post Novartis Glivec case ruling competition between MNC pharmaceuticals & Indian generic companies gets fierce as US based Merck Sharp & Dohme (MSD), the third largest pharma company by revenues , has filed a patent infringement suit with Delhi High court against domestic generic company Glenmark  Pharmaceuticals. MSD move comes a week after Glenmark [...]

By |2017-09-07T15:10:28+05:30April 7th, 2013|Patent|0 Comments

S.C. REFUSED NOVARTIS PATENT ON GLIVEC

India’s Supreme Court has set an important precedent in refusing to grant a patent to Novartis for an updated version of its cancer drug Glivec. The verdict will allow generic drug makers within the country to continue selling cheap versions of the drug, which is used to treat chronic myeloid leukemia and other cancers. [...]

By |2017-09-07T15:09:19+05:30April 7th, 2013|IP Basics, Patent|0 Comments

January Session PGD in Patent Law and Management

IIPTA (Indian Institute of Patent and Trademark Attorney) has announced open admissions for January session of Post Graduate Diploma in Patent Law and Management a unique program covering the management aspects of patent world. The curriculum is divided into 10 books each covering different aspect of Patent Management. Curriculum 1 PRIMER TO INTELLECTUAL PROPERTY [...]

By |2017-09-07T12:02:05+05:30September 27th, 2011|Patent|0 Comments
Go to Top